CADL: Candel Company Cash on Hand

Official company branding of Candel Therapeutics, Inc. (CADL)

Candel Therapeutics (CADL) actively collaborates with oncology centers to research methods for combating lung and brain tumors. Operating cash flow data on GURU.Markets illustrates liquidity dynamics, where 0.20 determines the current level of this parameter. Stability is provided by diversified plants in the US and laboratories in Massachusetts, while seamless cold chains ensure strict adherence to medical protocols during therapy deliveries.

Candel Therapeutics - CADL Company Total Cash Amount (period 07/04/2022 - 11/21/2026)

Summary analytical data breakdowns for candeltx.com (CADL)

- stock value and consensus price forecast:
- cash balance and cash flow data:
Fundamental valuation:Candel Therapeutics Inc.
Brand item of Candel Therapeutics

For a biotech sector investor, the stability of Candel Therapeutics (CADL) is determined by its ability to fund capital-intensive development. This metric measures the volume of liquid assets required to cover operating expenses and prevent default in the absence of revenue. Analyzing the cash balance allows for an assessment of the company's autonomy horizon regarding the payroll of leading immunologists and R&D expenditures. A stable liquidity reserve confirms the long-term viability of ambitious scientific projects.

Analysis of competing companies

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Funds Accuray Inc ARAY|Company Liquid Assets SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Company Cash Volume|Company Cash Reserve Citius Oncology|HURA: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds